Torrent Pharma moves up on getting nod to raise upto Rs 12,500 crore through NCDs
Torrent Pharmaceuticals is currently trading at Rs. 3922.85, up by 53.40 points or 1.38% from its previous closing of Rs. 3869.45 on the BSE.
The scrip opened at Rs. 3881.05 and has touched a high and low of Rs. 3922.95 and Rs. 3862.65 respectively. So far 1603 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3,922.95 on 06-Jan-2026 and a 52 week low of Rs. 2891.45 on 03-Mar-2025.
Last one week high and low of the scrip stood at Rs. 3922.95 and Rs. 3796.95 respectively. The current market cap of the company is Rs. 132704.46 crore.
The promoters holding in the company stood at 68.31%, while Institutions and Non-Institutions held 25.27% and 6.42% respectively.
Torrent Pharmaceuticals has received approval from Securities Transfer and Stakeholders Relationship Committee (STSRC) for issuance of Secured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs) aggregating upto Rs 12,500 crore in one or more tranches on private placement basis.
Securities Transfer and Stakeholders Relationship Committee (STSRC) has at its meeting held on January 05, 2026 has approved the same.
Torrent Pharmaceuticals (Torrent Pharma) is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
